US Patent Issued to The Regents of the University of California on March 17 for "Anti-cancer activity of adamantane derivatives" (California Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,048, issued on March 17, was assigned to The Regents of the University of California (Oakland, Calif.).

"Anti-cancer activity of adamantane derivatives" was invented by Andrew Sharabi (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for treating cancer comprising administering to a subject in need thereof an adamantane derivative, or a pharmaceutically acceptable salt thereof, such as rimantadine or amantadine. In some embodiments, the adamantane derivative is PEGylated."

The patent was filed on Dec. 5, 2019, under Application No. 17/311,101.

*For further information, including images, charts and tables, pleas...